KabaFusion (the “Company”), a nationally recognized leader in home and alternative site infusion, and Nautic Partners (“Nautic”) announce that Nautic has completed its growth investment in KabaFusion. KabaFusion’s clinician-led management team remains significant investors and will continue to lead the Company, while Novo Holdings exited its successful investment in the Company. Headquartered in Cerritos, CA and Lexington, MA, KabaFusion was founded in 2010 by Chief Executive Officer Dr. Sohail Masood, a pioneer in patient-focused intravenous immunoglobulin (IVIG) infusion therapies. Today, KabaFusion is licensed to serve patients in 45 states through its expansive network of 33 infusion pharmacies and 21 ambulatory infusion suites.
Read the full article: KabaFusion and Nautic Partners Announce Completion of Significant Growth Investment //
Source: https://www.globenewswire.com/news-release/2026/02/02/3230441/0/en/KabaFusion-and-Nautic-Partners-Announce-Completion-of-Significant-Growth-Investment.html